The Partnership for Artificial Intelligence and Automation in Healthcare (PATH) is designed to bring together health systems, payers and regulators to navigate the barriers to adoption and implementation, among other priorities.
The new CEO of NuPathe (NASDAQ:PATH) followed through on his pledge to cut costs at the biopharmaceutical startup by reducing its workforce by half, according to documents filed with the Securities and Exchange Commission. The cuts, which would amount to the loss of 18 jobs from a staff of 43, come just three months before a PDUFA date for […]
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
The leadership change at NuPathe (NASDAQ:PATH) has ushered in a CEO with the sales and marketing background to bring its first product — a migraine patch — to market, a move that is likely to loosen up the purse strings of conservative investors. Tracy T. Lefteroff, managing partner of the venture capital practice at PricewaterhouseCoopers, […]
Biopharmaceutical firm NuPathe’s (NASDAQ:PATH) CEO Jane Hollingsworth has resigned as CEO and board member of the company she co-founded more than six years ago. She has been replaced by the former CEO of Auxilium Pharmaceuticals (NASDAQ:AUXL), another company Hollingsworth co-founded. The move comes as NuPathe gears up to commercialize its lead product the Zelrix […]
Jane Hollingsworth, the CEO of NuPathe (NASDAQ:PATH), tends to stand out around Philadelphia. It’s not just because she has founded two drug development companies — Auxilium Pharmaceuticals (NASDAQ:AUXL) and NuPathe — and taken them public. It’s also because the region is not exactly teeming with drug development startups led by women. Hollingsworth said one of […]